BREATHE Program for Asthma
Trial Summary
What is the purpose of this trial?
This study is an efficacy-implementation trial to: 1. evaluate systematically the efficacy of BREATHE in 200 Black adults receiving care at urban federally qualified health centers (FQHCs) for uncontrolled asthma; and 2. identify multi-level barriers and facilitators to the widespread adoption and implementation of BREATHE in FQHCs.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the BREATHE Intervention treatment for asthma?
Is the BREATHE Program for Asthma safe for humans?
How is the BREATHE Program for Asthma treatment different from other asthma treatments?
Research Team
Maureen George, PhD
Principal Investigator
Columbia University School of Nursing
Eligibility Criteria
The BREATHE trial is for Black adults with uncontrolled asthma who are at least 18 years old, receive care at urban FQHCs, and have been diagnosed with persistent asthma or had an exacerbation. Participants must self-identify as Black (of any ethnicity) and speak English. Excluded are those with serious mental health conditions that could affect participation.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a one-time 9-minute shared decision-making intervention integrated into an office visit for asthma management
Follow-up
Participants are monitored for asthma control, medication adherence, and quality of life improvements
Post-trial Interviews
Qualitative interviews conducted to assess satisfaction and acceptability of the intervention
Treatment Details
Interventions
- BREATHE Intervention
- Control Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator